Literature DB >> 16061701

A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.

F Lose1, P J Thompson, D Duffy, G A Stewart, M-A Kedda.   

Abstract

BACKGROUND: Airway remodelling is a characteristic feature of chronic asthma and there is evidence that an airway imbalance between levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) is associated with airway remodelling. On this basis, we hypothesised that polymorphisms in the MMP-9 and TIMP-1 genes were associated with the disease process.
METHODS: A number of MMP-9 and TIMP-1 gene polymorphisms were examined in an adult white Australian population of mild (n = 259), moderate (n = 213) and severe (n = 71) asthmatics and non-asthmatic controls (n = 406) using PCR-RFLP and PCR-SSCP analyses.
RESULTS: MMP-9 -1562C>T and 836G>A (Arg279Gln) were not associated with asthma (p> or =0.15) or asthma severity (p> or =0.13), and TIMP-1 434T>C (Phe124Phe) was not associated with asthma in women (p = 0.094) or men (p = 0.207). In this population, MMP-9 -861C>T and TIMP-1 323C>T (Pro87Pro) were not informative (with minor allele frequencies of <1%), and MMP-9 -1702T>A and TIMP-1 595C>T (Ser178Phe) were not detectable. However, a novel polymorphism was detected in the TIMP-1 gene 536C>T (Ile158Ile) which was significantly associated with asthma in women (p = 0.011; OR = 5.54, 95% CI 1.66 to 34.4) but not in men (p = 1.0). 536C>T was found to be in linkage disequilibrium with 434T>C, and haplotype analysis supported an association with asthma (p = 0.014).
CONCLUSIONS: This is the first reported association between a polymorphism in the TIMP-1 gene and asthma, and supports the hypothesis that the protease/antiprotease balance has an important role in this common disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061701      PMCID: PMC1747496          DOI: 10.1136/thx.2004.026930

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

Review 1.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

2.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

3.  Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study.

Authors:  P J Pöllänen; P J Karhunen; J Mikkelsson; P Laippala; M Perola; A Penttilä; K M Mattila; T Koivula; T Lehtimäki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

4.  Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.

Authors:  Didier D Cataldo; Jane Bettiol; Agnes Noël; Pierre Bartsch; Jean-Michel Foidart; Renaud Louis
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.

Authors:  Waldo Mattos; Sam Lim; Richard Russell; Anon Jatakanon; K Fan Chung; Peter J Barnes
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

6.  Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.

Authors:  N Minematsu; H Nakamura; H Tateno; T Nakajima; K Yamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2001-11-23       Impact factor: 3.575

7.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair.

Authors:  Sally E Wenzel; Silvana Balzar; Meghan Cundall; Hong Wei Chu
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

9.  Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma.

Authors:  Y Oshita; T Koga; T Kamimura; K Matsuo; T Rikimaru; H Aizawa
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

10.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

View more
  14 in total

Review 1.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

2.  Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.

Authors:  Valeria Fabre; Haiwei Wu; Sunthorn PondTor; Hannah Coutinho; Luz Acosta; Mario Jiz; Remigio Olveda; Ling Cheng; Eric S White; Blanca Jarilla; Stephen T McGarvey; Jennifer F Friedman; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2011-01-03       Impact factor: 5.226

Review 3.  DNA sequence variations of metalloproteinases: their role in asthma and COPD.

Authors:  Fotis Sampsonas; Alexander Kaparianos; Dimosthenis Lykouras; Kiriakos Karkoulias; Kostas Spiropoulos
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

4.  Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.

Authors:  Mark F Sands; Patricia J Ohtake; Supriya D Mahajan; Shervin S Takyar; Ravikumar Aalinkeel; Yisheng V Fang; Jessica W Blume; Barbara A Mullan; Don E Sykes; Sandra Lachina; Paul R Knight; Stanley A Schwartz
Journal:  Clin Immunol       Date:  2008-10-26       Impact factor: 3.969

5.  MMP9 modulates tight junction integrity and cell viability in human airway epithelia.

Authors:  Paola D Vermeer; James Denker; Miriam Estin; Thomas O Moninger; Shaf Keshavjee; Philip Karp; Joel N Kline; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-06       Impact factor: 5.464

6.  Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Sarra Bchir; Hela Ben Nasr; Imen Rekik Hakim; Amel Ben Anes; Saloua Yacoub; Abdelhamid Garrouch; Mohamed Benzarti; Brigitte Bauvois; Zouhair Tabka; Karim Chahed
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

Review 7.  Susceptibility genes in severe asthma.

Authors:  Stephen T Holgate
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

8.  The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.

Authors:  Wojciech J Piotrowski; Paweł Górski; Tadeusz Pietras; Wojciech Fendler; Janusz Szemraj
Journal:  Med Sci Monit       Date:  2011-10

9.  Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.

Authors:  Li-Hsiou Chen; Kuo-Liang Chiu; Te-Chun Hsia; Yen-Hsien Lee; Te-Chun Shen; Chia-Hsiang Li; Yi-Cheng Shen; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

10.  The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma.

Authors:  Manish Kumar; D P Bhadoria; Koushik Dutta; Mitesh Kumar F; Bharat Singh; Seema Singh; Anil K Chhillar; D Behera; G L Sharma
Journal:  Comp Funct Genomics       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.